1. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects;Bianchi-Porro, G.; Prada, A.; Petrillo, M.;Scand J Gastroenterol,1979
2. Influence of intravenous pirenzepine, a selective anticholinergic agent, in patients with Zollinger-Ellison syndrome;El-Sabbagh, H.N.; Prinze, R.A.; Welbourn, R.B.; Baron, J.H.;Scand J Gastroenterol
3. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer;Konturek, S.J.; Obtulowicz, W.; Kwiecien, N.;Scand J Gastroenterol
4. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man;Londong, W.; Prechtl, Londong V.; R, Weber; TH, von Werder; K.;Scand J Gastroenterol
5. Muscarinic receptors in the stomach;Hammer, R.;Scand J Gastroenterol